Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

Previous reports identifying discordance between multiparameter tests at the individual patient level have been largely attributed to methodological shortcomings of multiple in silico studies. Comparisons between tests, when performed using actual diagnostic assays, have been predicted to demonstrat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2016-09, Vol.108 (9), p.djw050
Hauptverfasser:	Bartlett, John M S, Bayani, Jane, Marshall, Andrea, Dunn, Janet A, Campbell, Amy, Cunningham, Carrie, Sobol, Monika S, Hall, Peter S, Poole, Christopher J, Cameron, David A, Earl, Helena M, Rea, Daniel W, Macpherson, Iain R, Canney, Peter, Francis, Adele, McCabe, Christopher, Pinder, Sarah E, Hughes-Davies, Luke, Makris, Andreas, Stein, Robert C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents, Hormonal - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Breast Neoplasms - chemistry Breast Neoplasms - classification Breast Neoplasms - drug therapy Breast Neoplasms - pathology Clinical Decision-Making Confidence Intervals Decision Support Techniques Female Humans Lymphatic Metastasis Middle Aged Neoplasm Recurrence, Local - drug therapy Nomograms Predictive Value of Tests Prognosis Receptor, ErbB-2 - analysis Receptors, Estrogen - analysis Risk Assessment - methods Tumor Burden
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!